We've found
161,353
archived clinical trials in
Cancer
We've found
161,353
archived clinical trials in
Cancer
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Updated: 11/14/2015
Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck
Status: Enrolling
Updated: 11/14/2015
Click here to add this to my saved trials
